Humacyte Acellular Tissue Engineered Vessel (ATEV)

Acellular Tissue Engineered Vessel · Humacyte, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Humacyte Acellular Tissue Engineered Vessel (ATEV), covering 2026-07-29 to 2026-07-29. Get the full timeline:

Most recent: Clinical Trial Results: Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma [Phase 2, Phase 3]

See pricing